Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India
India launched its coronavirus disease 2019 (COVID-19) vaccination drive starting with healthcare workers. The aim of the study was to evaluate adverse events following immunization (AEFI) amongst the Geriatric population associated with two doses of ChAdOx1 nCoV-19 vaccine. We also evaluated associ...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2022-01-01
|
| Series: | Geriatric Care |
| Subjects: | |
| Online Access: | https://www.pagepressjournals.org/index.php/gc/article/view/9908 |
| _version_ | 1828833551432286208 |
|---|---|
| author | Anil Bhandari Surya Pratap Singh Tiwari Monika Rathore Lokendra Sharma Smita Jain |
| author_facet | Anil Bhandari Surya Pratap Singh Tiwari Monika Rathore Lokendra Sharma Smita Jain |
| author_sort | Anil Bhandari |
| collection | DOAJ |
| description | India launched its coronavirus disease 2019 (COVID-19) vaccination drive starting with healthcare workers. The aim of the study was to evaluate adverse events following immunization (AEFI) amongst the Geriatric population associated with two doses of ChAdOx1 nCoV-19 vaccine. We also evaluated association of AEFI according to gender and elderly age groups. An observational study, conducted among 437 individuals vaccinated at multiple community healthcare centers in Jaipur, of AEFIs associated with both doses of ChAdOx1 nCoV-19 vaccine, via telephonic interviews on the day of vaccination-Day 0, Day 7 and Day 15 from vaccination. 463 vaccinated individuals who responded for first dose AEFIs, and 437 (94.3% 437/463) responded to the telephone interview regarding the second dose. Of these, 5.5% (24/437) reported AEFIs for the second dose. Among 60 respondents who reported AEFI (both doses) fever (26) and fatigue (22) were the most reported systemic AEFI. Local AEFIs were injection site soreness (23). The AEFIs (both systemic and local) in respondents mostly lasted for 1-2 days. AEFI reported by respondents in the age group 60- 70 years was higher than those above 70 years. Female respondents were associated with higher AEFI than the males. The AEFIs of both the doses were observed in the first 2 days predominantly. Symptoms were minor, short lived and selflimiting. No serious adverse events attributable to vaccines were reported in our study. Adverse event following immunization is independent of gender and age distribution for both the doses. |
| first_indexed | 2024-12-12T17:20:57Z |
| format | Article |
| id | doaj.art-4ad84ad559e34dbfae3c1bea0f5f746c |
| institution | Directory Open Access Journal |
| issn | 2465-1109 2465-1397 |
| language | English |
| last_indexed | 2024-12-12T17:20:57Z |
| publishDate | 2022-01-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Geriatric Care |
| spelling | doaj.art-4ad84ad559e34dbfae3c1bea0f5f746c2022-12-22T00:17:38ZengPAGEPress PublicationsGeriatric Care2465-11092465-13972022-01-017410.4081/gc.2021.9908Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, IndiaAnil Bhandari0Surya Pratap Singh Tiwari1Monika Rathore2Lokendra Sharma3Smita Jain4Department of Pharmacology, SMS Medical College, JaipurSMS Medical College, JaipurDepartment of Community Medicine, SMS Medical College, JaipurDepartment of Pharmacology, SMS Medical College, JaipurDepartment of Mathematics, JECRC University of Jaipur, Jaipur, RajasthanIndia launched its coronavirus disease 2019 (COVID-19) vaccination drive starting with healthcare workers. The aim of the study was to evaluate adverse events following immunization (AEFI) amongst the Geriatric population associated with two doses of ChAdOx1 nCoV-19 vaccine. We also evaluated association of AEFI according to gender and elderly age groups. An observational study, conducted among 437 individuals vaccinated at multiple community healthcare centers in Jaipur, of AEFIs associated with both doses of ChAdOx1 nCoV-19 vaccine, via telephonic interviews on the day of vaccination-Day 0, Day 7 and Day 15 from vaccination. 463 vaccinated individuals who responded for first dose AEFIs, and 437 (94.3% 437/463) responded to the telephone interview regarding the second dose. Of these, 5.5% (24/437) reported AEFIs for the second dose. Among 60 respondents who reported AEFI (both doses) fever (26) and fatigue (22) were the most reported systemic AEFI. Local AEFIs were injection site soreness (23). The AEFIs (both systemic and local) in respondents mostly lasted for 1-2 days. AEFI reported by respondents in the age group 60- 70 years was higher than those above 70 years. Female respondents were associated with higher AEFI than the males. The AEFIs of both the doses were observed in the first 2 days predominantly. Symptoms were minor, short lived and selflimiting. No serious adverse events attributable to vaccines were reported in our study. Adverse event following immunization is independent of gender and age distribution for both the doses.https://www.pagepressjournals.org/index.php/gc/article/view/9908COVID-19 vaccineChAdOx1nCoV-19adverse events following immunization. |
| spellingShingle | Anil Bhandari Surya Pratap Singh Tiwari Monika Rathore Lokendra Sharma Smita Jain Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India Geriatric Care COVID-19 vaccine ChAdOx1nCoV-19 adverse events following immunization. |
| title | Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India |
| title_full | Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India |
| title_fullStr | Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India |
| title_full_unstemmed | Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India |
| title_short | Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India |
| title_sort | active surveillance of adverse events following chadox1 ncov 19 immunization in geriatric population a prospective multi centric study from jaipur rajasthan india |
| topic | COVID-19 vaccine ChAdOx1nCoV-19 adverse events following immunization. |
| url | https://www.pagepressjournals.org/index.php/gc/article/view/9908 |
| work_keys_str_mv | AT anilbhandari activesurveillanceofadverseeventsfollowingchadox1ncov19immunizationingeriatricpopulationaprospectivemulticentricstudyfromjaipurrajasthanindia AT suryapratapsinghtiwari activesurveillanceofadverseeventsfollowingchadox1ncov19immunizationingeriatricpopulationaprospectivemulticentricstudyfromjaipurrajasthanindia AT monikarathore activesurveillanceofadverseeventsfollowingchadox1ncov19immunizationingeriatricpopulationaprospectivemulticentricstudyfromjaipurrajasthanindia AT lokendrasharma activesurveillanceofadverseeventsfollowingchadox1ncov19immunizationingeriatricpopulationaprospectivemulticentricstudyfromjaipurrajasthanindia AT smitajain activesurveillanceofadverseeventsfollowingchadox1ncov19immunizationingeriatricpopulationaprospectivemulticentricstudyfromjaipurrajasthanindia |